AstraZeneca PLC Ownership
| ZEGA Stock | EUR 63.50 1.00 1.60% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
AstraZeneca |
AstraZeneca Stock Ownership Analysis
About 18.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.35. AstraZeneca PLC last dividend was issued on the 23rd of February 2023. The entity had 2:1 split on the 27th of July 2015. AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom. ASTRAZENECA operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 64400 people. For more information please call Marc Dunoyer at 44 20 3749 5000 or visit https://www.astrazeneca.com.AstraZeneca PLC Outstanding Bonds
AstraZeneca PLC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. AstraZeneca PLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most AstraZeneca bonds can be classified according to their maturity, which is the date when AstraZeneca PLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| ASTRAZENECA PLC 645 Corp BondUS046353AD01 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| ASTRAZENECA PLC 3375 Corp BondUS046353AL27 | View | |
| ASTRAZENECA PLC 4375 Corp BondUS046353AM00 | View | |
| ASTRAZENECA PLC 4 Corp BondUS046353AG32 | View | |
| ASTRAZENECA PLC 4 Corp BondUS046353AT52 | View |
Currently Active Assets on Macroaxis
Other Information on Investing in AstraZeneca Stock
AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.